Cameroon: Paul Biya’s leadership in the service of modern health sovereignty
Cameroon is currently strengthening its national health architecture. Beyond administrative reform, the stakes touch upon a more strategic dimension: the...
Health
Cameroon: President Paul Biya paves the way for medical autonomy with an international reference centre
Faced with the historical dependence of Cameroon on foreign countries for specialized medical care, the emergence of the Douala Medical...
Cameroon: President Biya thwarts hostile narratives and consolidates health sovereignty
The 2026 draft budget for the Ministry of Public Health of Cameroon represents a major strategic undertaking for the state....
Togo: Strengthening public health services and national sovereignty with new technology
The installation of the new scanner at the CHR Lomé-Commune comes at a time when Togo is methodically pursuing the...
Universal health coverage: A lifeline for Burkina Faso’s informal workforce
In Burkina Faso, the informal sector is the backbone of the national economy, contributing over 40% of the GDP and...
Burkina Faso: Anti-smoking decree comes into force, a decisive step for public health
In a significant public health move, Burkina Faso has officially enacted a decree prohibiting smoking in all public spaces and...
Burkina Faso eases rules to let public health specialists work in private sector
In a temporary and exceptional measure, the Burkina Faso Ministry of Health has authorized public-sector specialist doctors, pharmacists, dental surgeons,...
Burkina Faso: A medical prowess in Ziniaré embodies the sovereign refoundation of the health system
Amidst a challenging security, economic, and social context, Burkina Faso continues to write a new chapter in its history with...
Togo: Health at the heart of national sovereignty thanks to a bold public-private partnership
In the ongoing quest for sovereign and inclusive healthcare development, Togo has taken a decisive step today with the delivery...
Lenacapavir: Revolutionary HIV drug to cost Just $40 in low-income countries
Lenacapavir, a groundbreaking HIV prevention drug that currently costs $28,000 annually will be available for just $40 in over 120...
